Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 27;7(3):e014538.
doi: 10.1136/bmjopen-2016-014538.

Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review

María Núñez-Núñez  1   2   3 , María Dolores Navarro  1   2 , Panagiota Gkolia  4 , Nithya Babu Rajendran  4 , María Dolores Del Toro  1   2 , Andreas Voss  5 , Mike Sharland  6 , Frangiscos Sifakis  7 , Evelina Tacconelli  4 , Jesús Rodríguez-Baño  1   2 ; Members of the EPI-NET group on behalf of COMBACTE-MAGNET Consortium
Affiliations

Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review

María Núñez-Núñez et al. BMJ Open. .

Abstract

Introduction: The worldwide spread of antimicrobial resistance is now recognised as a global public health threat. Owing to the geographical heterogeneity, complexity and continuously evolving dynamics of resistant organisms and genes, surveillance is a key tool for understanding, measuring and informing actions in the fight against this problem. To date there is no harmonisation of key indicators or of methodologies used to obtain them.

Methods and analysis: The main objective of this project is to systematically review and analyse the current publicly available surveillance activities on antimicrobial resistance and healthcare-associated infections in Europe. Eligible activities are those endorsed by regional, national or transnational health organisations and scientific societies providing data on a periodic basis. Grey and peer-reviewed literature will be searched with no language restrictions. Three independent reviewers will perform a two-step selection process using a previously piloted, tailored electronic data extraction form. Descriptive summaries and tables of all relevant findings will be performed and reported according to PRISMA guidelines.

Ethics and dissemination: We did not seek ethical approval for this study because the data to be collected are not linked to individuals. Data will be presented at international conferences and published in peer-reviewed journals.

Trial registration number: CRD42016033867.

Keywords: Antimicrobial resistance; healthcare-associated infections; surveillance.

PubMed Disclaimer

Conflict of interest statement

Competing interests: FS is an employee of AstraZeneca/Medimmune, an EFPIA (European Federation of Pharmaceutical Industries and Association) member company in the IMI JU. Costs related to research contributions by FS are borne by AstraZeneca/Medimmune and considered in-kind contribution under the IMI JU scheme. Rest of authors has declared no conflict of interest related to this paper.

References

    1. European commission. Action plan against the rising threats from Antimicrobial Resistance. Communication from the commission to the European parliament and the council. Brussels, September 2011. http://ec.europa.eu/dgs/health_consumer/docs/communication_amr_2011_748_...
    1. ECDC/EMEA Joint technical report. The bacterial challenge: time to react. Ref. EMEA/576176/2009. Stockholm, September 2009. ISBN 978-92-9193-193-4 10.2900/2518 - DOI
    1. European Centre for Disease Prevention and Control (ECDC), website available on. http://ecdc.europa.eu/en/activities/surveillance/Pages/index.aspx (date last accessed September 2016).
    1. Centers for Disease Control and Prevention (CDC). http://www.cdc.gov/nhsn (date last accessed September 2016).
    1. World Health Organization (WHO). http://www.who.int/topics/public_health_surveillance/en/ (date last accessed September 2016).